Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Link Pharma Chem Ltd has informed the stock exchanges that its trading window will be closed starting 1st January 2026 in line with SEBI's insider trading regulations. The window will stay shut until 48 hours after the company announces its unaudited financial results for the third quarter and nine months ending 31st December 2025. The exact date of the board meeting to consider these results will be communicated separately. The intimation was signed by Managing Director Rishikesh Thakur.
This is a routine regulatory filing with no direct impact on shareholders. It signals that the company is preparing to declare its Q3 and nine-month financial results soon, and that directors, key managerial personnel, and their immediate relatives are barred from trading in the stock during this period.